LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 77

Search options

  1. Article ; Online: The Influence of n-3PUFA Supplementation on Muscle Strength, Mass, and Function: A Systematic Review and Meta-Analysis.

    Santo André, Heloisa C / Esteves, Gabriel P / Barreto, Gabriel H C / Longhini, Fernando / Dolan, Eimear / Benatti, Fabiana B

    Advances in nutrition (Bethesda, Md.)

    2022  Volume 14, Issue 1, Page(s) 115–127

    Abstract: The effects of omega 3 polyunsaturated fatty acids (n-3PUFA) supplementation on skeletal muscle are currently unclear. The purpose of this systematic review was to synthesize all available evidence regarding the influence of n-3PUFA supplementation on ... ...

    Abstract The effects of omega 3 polyunsaturated fatty acids (n-3PUFA) supplementation on skeletal muscle are currently unclear. The purpose of this systematic review was to synthesize all available evidence regarding the influence of n-3PUFA supplementation on muscle mass, strength, and function in healthy young and older adults. Four databases were searched (Medline, Embase, Cochrane CENTRAL, and SportDiscus). Predefined eligibility criteria were determined according to Population, Intervention, Comparator, Outcomes, and Study Design. Only peer-reviewed studies were included. The Cochrane RoB2 Tool and the NutriGrade approach were used to access risk of bias and certainty in evidence. Effect sizes were calculated using pre-post scores and analyzed using a three-level, random-effects meta-analysis. When sufficient studies were available, subanalyses were performed in the muscle mass, strength, and function outcomes according to participant's age (<60 or ≥60 years), supplementation dosage (<2 or ≥2 g/day), and training intervention ("resistance training" vs. "none or other"). Overall, 14 individual studies were included, total 1443 participants (913 females; 520 males) and 52 outcomes measures. Studies had high overall risk of bias and consideration of all NutriGrade elements resulted in a certainty assessment of moderate meta-evidence for all outcomes. n-3PUFA supplementation had no significant effect on muscle mass (standard mean difference [SMD] = 0.07 [95% CI: -0.02, 0.17], P = 0.11) and muscle function (SMD = 0.03 [95% CI: -0.09, 0.15], P = 0.58), but it showed a very small albeit significant positive effect on muscle strength (SMD = 0.12 [95% CI: 0.006, 0.24], P = 0.04) in participants when compared with placebo. Subgroup analyses showed that age, supplementation dose, or cosupplementation alongside resistance training did not influence these responses. In conclusion, our analyses indicated that n-3PUFA supplementation may lead to very small increases in muscle strength but did not impact muscle mass and function in healthy young and older adults. To our knowledge, this is the first review and meta-analysis investigating whether n-3PUFA supplementation can lead to increases in muscle strength, mass, and function in healthy adults. Registered protocol: doi.org/10.17605/OSF.IO/2FWQT.
    MeSH term(s) Male ; Female ; Humans ; Aged ; Middle Aged ; Muscle, Skeletal/physiology ; Fatty Acids, Omega-3 ; Muscle Strength ; Health Status ; Dietary Supplements
    Chemical Substances Fatty Acids, Omega-3
    Language English
    Publishing date 2022-12-24
    Publishing country United States
    Document type Meta-Analysis ; Systematic Review ; Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2583634-1
    ISSN 2156-5376 ; 2156-5376
    ISSN (online) 2156-5376
    ISSN 2156-5376
    DOI 10.1016/j.advnut.2022.11.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation.

    Benatti, Fabiana B / Pedersen, Bente K

    Nature reviews. Rheumatology

    2015  Volume 11, Issue 2, Page(s) 86–97

    Abstract: Persistent systemic inflammation, a typical feature of inflammatory rheumatic diseases, is associated with a high cardiovascular risk and predisposes to metabolic disorders and muscle wasting. These disorders can lead to disability and decreased physical ...

    Abstract Persistent systemic inflammation, a typical feature of inflammatory rheumatic diseases, is associated with a high cardiovascular risk and predisposes to metabolic disorders and muscle wasting. These disorders can lead to disability and decreased physical activity, exacerbating inflammation and the development of a network of chronic diseases, thus establishing a 'vicious cycle' of chronic inflammation. During the past two decades, advances in research have shed light on the role of exercise as a therapy for rheumatic diseases. One of the most important of these advances is the discovery that skeletal muscle communicates with other organs by secreting proteins called myokines. Some myokines are thought to induce anti-inflammatory responses with each bout of exercise and mediate long-term exercise-induced improvements in cardiovascular risk factors, having an indirect anti-inflammatory effect. Therefore, contrary to fears that physical activity might aggravate inflammatory pathways, exercise is now believed to be a potential treatment for patients with rheumatic diseases. In this Review, we discuss how exercise disrupts the vicious cycle of chronic inflammation directly, after each bout of exercise, and indirectly, by improving comorbidities and cardiovascular risk factors. We also discuss the mechanisms by which some myokines have anti-inflammatory functions in inflammatory rheumatic diseases.
    MeSH term(s) Adiposity/physiology ; Body Composition ; Exercise Therapy ; Humans ; Inflammation/physiopathology ; Inflammation/therapy ; Interleukin-6/physiology ; Muscle, Skeletal/physiopathology ; Rheumatic Diseases/physiopathology ; Rheumatic Diseases/rehabilitation ; Rheumatic Diseases/therapy ; Scleroderma, Systemic/therapy ; Tumor Necrosis Factor-alpha/physiology
    Chemical Substances Interleukin-6 ; Tumor Necrosis Factor-alpha
    Language English
    Publishing date 2015-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2491532-4
    ISSN 1759-4804 ; 1759-4790
    ISSN (online) 1759-4804
    ISSN 1759-4790
    DOI 10.1038/nrrheum.2014.193
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Health at Every Size®-Based Interventions May Improve Cardiometabolic Risk and Quality of Life Even in the Absence of Weight Loss: An Ancillary, Exploratory Analysis of the Health and Wellness in Obesity Study.

    Dimitrov Ulian, Mariana / Pinto, Ana Jéssica / de Morais Sato, Priscila / Benatti, Fabiana B / Lopes de Campos-Ferraz, Patricia / Coelho, Desire / Roble, Odilon J / Sabatini, Fernanda / Perez, Isabel / Aburad, Luiz / Vessoni, André / Fernandez Unsain, Ramiro / Rogero, Marcelo Macedo / Sampaio, Geni / Gualano, Bruno / Scagliusi, Fernanda B

    Frontiers in nutrition

    2022  Volume 9, Page(s) 598920

    Abstract: We examined whether weight loss following HAES®-based interventions associates with changes in cardiometabolic risk factors and quality of life of women with obesity. This was an exploratory, ancillary analysis of a 7-month, mixed-method, randomized ... ...

    Abstract We examined whether weight loss following HAES®-based interventions associates with changes in cardiometabolic risk factors and quality of life of women with obesity. This was an exploratory, ancillary analysis of a 7-month, mixed-method, randomized controlled trial. Fifty-five women (age: 33.0 ± 7.2; BMI: 30-39.9 kg/m
    Language English
    Publishing date 2022-02-22
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2776676-7
    ISSN 2296-861X
    ISSN 2296-861X
    DOI 10.3389/fnut.2022.598920
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Effects of a lifestyle intervention on cardiovascular risk factors in systemic lupus erythematosus patients: The study "Living well with lupus".

    Sieczkowska, Sofia Mendes / Mazzolani, Bruna Caruso / Smaira, Fabiana Infante / Romero, Marina / Pasoto, Sandra Gofinet / de Sá Pinto, Ana Lúcia / Lima, Fernanda Rodrigues / De Oliveira, Victor Rodrigues / Ueda, Serli / Benatti, Fabiana Braga / Roschel, Hamilton / Gualano, Bruno

    Clinical rheumatology

    2024  Volume 43, Issue 3, Page(s) 1003–1013

    Abstract: Objective: The aim of the present study was to investigate the effects of a lifestyle intervention on cardiometabolic risk factors in patients with systemic lupus erythematosus with a high cardiovascular risk profile.: Methods: This trial was ... ...

    Abstract Objective: The aim of the present study was to investigate the effects of a lifestyle intervention on cardiometabolic risk factors in patients with systemic lupus erythematosus with a high cardiovascular risk profile.
    Methods: This trial was conducted in Sao Paulo, Brazil between August 2020 and March 2023. The patients were randomly assigned to lifestyle intervention or control. The intervention was a 6-month multifaced program focused on behavioral changes through personalized recommendations for increasing physical activity (structured and non-structured) and improving eating aspects. Cardiometabolic risk score (primary outcome), anthropometry and visceral fat, aerobic capacity, blood pressure, inflammatory and oxidative stress markers, and blood flow and endothelial function were assessed before and after the intervention.
    Results: A total of 80 patients were randomized. Twelve and 6 patients dropped out due to personal reasons in the intervention and control groups, respectively. Average adherence rate for the intervention was 56.9%. Intention-to-treat analysis showed no significant difference between groups in the cardiometabolic risk score (intervention group - Pre: 1.7 ± 3.6; Post: -1.6 ± 4.0; control group - Pre: -1.9 ± 3.6; Post: -2.0 ± 3.8; estimated mean difference between groups at post: -0.4; 95% confidence intervals: -2.7; 1.9; p = 0.96). This finding was confirmed by exploratory, per-protocol analysis. No significant differences were observed between adherents vs. non-adherent participants. Secondary outcomes did not change between groups.
    Conclusion: This 6-month, individualized, lifestyle intervention did not improve cardiovascular risk factors in SLE patients with a high cardiovascular risk profile.
    Trial registration: clinicaltrials.gov (NCT04431167).
    MeSH term(s) Humans ; Risk Factors ; Cardiovascular Diseases/prevention & control ; Brazil ; Life Style ; Heart Disease Risk Factors ; Lupus Erythematosus, Systemic/complications ; Lupus Erythematosus, Systemic/therapy
    Language English
    Publishing date 2024-01-27
    Publishing country Germany
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 604755-5
    ISSN 1434-9949 ; 0770-3198
    ISSN (online) 1434-9949
    ISSN 0770-3198
    DOI 10.1007/s10067-024-06870-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Selective alterations of endocannabinoid system genes expression in obsessive compulsive disorder.

    Bellia, Fabio / Girella, Antonio / Annunzi, Eugenia / Benatti, Beatrice / Vismara, Matteo / Priori, Alberto / Festucci, Fabiana / Fanti, Federico / Compagnone, Dario / Adriani, Walter / Dell'Osso, Bernardo / D'Addario, Claudio

    Translational psychiatry

    2024  Volume 14, Issue 1, Page(s) 118

    Abstract: Obsessive Compulsive Disorder (OCD) is listed as one of the top 10 most disabling neuropsychiatric conditions in the world. The neurobiology of OCD has not been completely understood and efforts are needed in order to develop new treatments. Beside the ... ...

    Abstract Obsessive Compulsive Disorder (OCD) is listed as one of the top 10 most disabling neuropsychiatric conditions in the world. The neurobiology of OCD has not been completely understood and efforts are needed in order to develop new treatments. Beside the classical neurotransmitter systems and signalling pathways implicated in OCD, the possible involvement of the endocannabinoid system (ECS) has emerged in pathophysiology of OCD. We report here selective downregulation of the genes coding for enzymes allowing the synthesis of the endocannabinoids. We found reduced DAGLα and NAPE-PLD in blood samples of individuals with OCD (when compared to healthy controls) as well as in the amygdala complex and prefrontal cortex of dopamine transporter (DAT) heterozygous rats, manifesting compulsive behaviours. Also mRNA levels of the genes coding for cannabinoid receptors type 1 and type 2 resulted downregulated, respectively in the rat amygdala and in human blood. Moreover, NAPE-PLD changes in gene expression resulted to be associated with an increase in DNA methylation at gene promoter, and the modulation of this gene in OCD appears to be correlated to the progression of the disease. Finally, the alterations observed in ECS genes expression appears to be correlated with the modulation in oxytocin receptor gene expression, consistently with what recently reported. Overall, we confirm here a role for ECS in OCD at both preclinical and clinical level. Many potential biomarkers are suggested among its components, in particular NAPE-PLD, that might be of help for a prompt and clear diagnosis.
    MeSH term(s) Humans ; Rats ; Animals ; Endocannabinoids/genetics ; Obsessive-Compulsive Disorder ; Amygdala/metabolism ; Prefrontal Cortex/metabolism ; DNA Methylation
    Chemical Substances Endocannabinoids
    Language English
    Publishing date 2024-02-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2609311-X
    ISSN 2158-3188 ; 2158-3188
    ISSN (online) 2158-3188
    ISSN 2158-3188
    DOI 10.1038/s41398-024-02829-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: "

    Santo André, Heloisa C / Pinto, Ana Jessica / Mazzolani, Bruna Caruso / Smaira, Fabiana Infante / Ulian, Mariana Dimitrov / Gualano, Bruno / Benatti, Fabiana Braga

    Frontiers in nutrition

    2022  Volume 8, Page(s) 665654

    Abstract: Aim: ...

    Abstract Aim:
    Language English
    Publishing date 2022-01-06
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2776676-7
    ISSN 2296-861X
    ISSN 2296-861X
    DOI 10.3389/fnut.2021.665654
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Acute cardiometabolic effects of brief active breaks in sitting for patients with rheumatoid arthritis.

    Pinto, Ana J / Meireles, Kamila / Peçanha, Tiago / Mazzolani, Bruna C / Smaira, Fabiana I / Rezende, Diego / Benatti, Fabiana B / Ribeiro, Ana C M / Pinto, Ana L S / Lima, Fernanda R / Shinjo, Samuel K / Dantas, Wagner S / Mellett, Natalie A / Meikle, Peter J / Owen, Neville / Dunstan, David W / Roschel, Hamilton / Gualano, Bruno

    American journal of physiology. Endocrinology and metabolism

    2021  Volume 321, Issue 6, Page(s) E782–E794

    Abstract: Exercise is a treatment in rheumatoid arthritis, but participation in moderate-to-vigorous exercise is challenging for some patients. Light-intensity breaks in sitting could be a promising alternative. We compared the acute effects of active breaks in ... ...

    Abstract Exercise is a treatment in rheumatoid arthritis, but participation in moderate-to-vigorous exercise is challenging for some patients. Light-intensity breaks in sitting could be a promising alternative. We compared the acute effects of active breaks in sitting with those of moderate-to-vigorous exercise on cardiometabolic risk markers in patients with rheumatoid arthritis. In a crossover fashion, 15 women with rheumatoid arthritis underwent three 8-h experimental conditions: prolonged sitting (SIT), 30-min bout of moderate-to-vigorous exercise followed by prolonged sitting (EX), and 3-min bouts of light-intensity walking every 30 min of sitting (BR). Postprandial glucose, insulin, c-peptide, triglycerides, cytokines, lipid classes/subclasses (lipidomics), and blood pressure responses were assessed. Muscle biopsies were collected following each session to assess targeted proteins/genes. Glucose [-28% in area under the curve (AUC),
    MeSH term(s) Aged ; Arthritis, Rheumatoid/metabolism ; Arthritis, Rheumatoid/physiopathology ; Arthritis, Rheumatoid/therapy ; Blood Glucose/metabolism ; Cardiometabolic Risk Factors ; Cardiovascular System/physiopathology ; Cross-Over Studies ; Energy Metabolism/physiology ; Exercise/physiology ; Female ; Humans ; Insulin/metabolism ; Middle Aged ; Postprandial Period ; Sedentary Behavior ; Walking/physiology
    Chemical Substances Blood Glucose ; Insulin
    Language English
    Publishing date 2021-10-25
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 603841-4
    ISSN 1522-1555 ; 0193-1849
    ISSN (online) 1522-1555
    ISSN 0193-1849
    DOI 10.1152/ajpendo.00259.2021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A randomized controlled trial of an intervention promoting physical activity and healthy eating recommendations in systemic lupus erythematosus: the protocol study "Living Well with Lupus".

    Sieczkowska, Sofia Mendes / Smaira, Fabiana Infante / Mazzolani, Bruna Caruso / Romero, Marina / Pasoto, Sandra Gofinet / de Sá Pinto, Ana Lúcia / Lima, Fernanda Rodrigues / De Oliveira, Victor Rodrigues / Ueda, Serli / Benatti, Fabiana Braga / Roschel, Hamilton / Gualano, Bruno

    Rheumatology international

    2023  Volume 43, Issue 10, Page(s) 1799–1810

    Abstract: There is a paucity of studies assessing multidisciplinary interventions focused on tackling physical inactivity/sedentary behavior and poor dietary habits in SLE. The Living well with Lupus (LWWL) is a randomized controlled trial to investigate whether a ...

    Abstract There is a paucity of studies assessing multidisciplinary interventions focused on tackling physical inactivity/sedentary behavior and poor dietary habits in SLE. The Living well with Lupus (LWWL) is a randomized controlled trial to investigate whether a six-month lifestyle change intervention will improve cardiometabolic risk factors (primary outcome) among systemic lupus erythematosus (SLE) patients with low disease activity (SLEDAI score ≤ 4) and with high cardiovascular risk. As secondary goals, we will evaluate: (1) the intervention's safety, efficacy, and feasibility in promoting lifestyle changes, and (2) the effects of the intervention on secondary outcomes (i.e., clinical parameters, functional capacity, fatigue, psychological aspects, sleep quality and health-related quality of life). Patients will be randomly allocated to either a control (i.e., standard care) or a lifestyle intervention group using a simple randomization (1:1 ratio, blocks of 20). Mixed Model analyses will be conducted for comparing groups following an intention-to-treat approach. A per protocol analysis will also be conducted. This study has the potential to generate new, clinically relevant data able to refine the multidisciplinary management of SLE patients. Protocol version number: NCT04431167 (first version).
    MeSH term(s) Humans ; Quality of Life ; Diet, Healthy ; Exercise ; Lupus Erythematosus, Systemic/drug therapy ; Life Style ; Randomized Controlled Trials as Topic
    Language English
    Publishing date 2023-06-24
    Publishing country Germany
    Document type Clinical Trial Protocol ; Journal Article
    ZDB-ID 8286-7
    ISSN 1437-160X ; 0172-8172
    ISSN (online) 1437-160X
    ISSN 0172-8172
    DOI 10.1007/s00296-023-05370-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Erratum. Exercise-Induced Increases in Insulin Sensitivity After Bariatric Surgery Are Mediated By Muscle Extracellular Matrix Remodeling. Diabetes 2020;69:1675-1691.

    Dantas, Wagner S / Roschel, Hamilton / Murai, Igor H / Gil, Saulo / Davuluri, Gangarao / Axelrod, Christopher L / Ghosh, Sujoy / Newman, Susan S / Zhang, Hui / Shinjo, Samuel K / das Neves, Willian / Merege-Filho, Carlos / Teodoro, Walcy R / Capelozzi, Vera L / Pereira, Rosa Maria / Benatti, Fabiana B / de Sá-Pinto, Ana L / de Cleva, Roberto / Santo, Marco A /
    Kirwan, John P / Gualano, Bruno

    Diabetes

    2021  Volume 70, Issue 6, Page(s) 1415

    Language English
    Publishing date 2021-05-11
    Publishing country United States
    Document type Journal Article ; Published Erratum
    ZDB-ID 80085-5
    ISSN 1939-327X ; 0012-1797
    ISSN (online) 1939-327X
    ISSN 0012-1797
    DOI 10.2337/db21-er06b
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Quality of life, fatigue, sleep quality, and mental health in systemic lupus erythematosus patients with a high cardiovascular risk profile.

    Caruso Mazzolani, Bruna / Infante Smaira, Fabiana / Mendes Sieczkowska, Sofia / Romero, Marina / Toledo Ribeiro, Thainá / Cordeiro Amarante, Milla / Pasoto, Sandra / de Sá Pinto, Ana Lúcia / Rodrigues Lima, Fernanda / Braga Benatti, Fabiana / Bonfa, Eloísa / Roschel, Hamilton / Gualano, Bruno

    Lupus

    2023  Volume 32, Issue 11, Page(s) 1287–1295

    Abstract: Systemic lupus erythematosus (SLE) patients report worse health-related quality of life (HRQL), fatigue, anxiety, depression, and sleep quality, when compared to the general population and other chronic diseases. Furthermore, cardiometabolic diseases are ...

    Abstract Systemic lupus erythematosus (SLE) patients report worse health-related quality of life (HRQL), fatigue, anxiety, depression, and sleep quality, when compared to the general population and other chronic diseases. Furthermore, cardiometabolic diseases are highly prevalent in SLE and are also associated with these parameters. Thus, it is plausible to suggest that SLE patients with a high cardiovascular risk may report worse results for these parameters. The aim of the study is to describe HRQL, fatigue, anxiety and depression symptoms, and sleep quality in a sample of SLE patients with a high cardiovascular risk profile (i.e., BMI between 25 and 40 kg/m
    Language English
    Publishing date 2023-09-12
    Publishing country England
    Document type Journal Article
    ZDB-ID 1154407-7
    ISSN 1477-0962 ; 0961-2033
    ISSN (online) 1477-0962
    ISSN 0961-2033
    DOI 10.1177/09612033231202582
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top